Last year I reported that the COVID-19 pandemic drove tremendous growth in demand for over-the-counter medicines for pain and fever, dietary supplements for immune support and wellness, and consumer medical devices for self-diagnosis and protection.
As the COVID-19 pandemic enters its third year, the public health emergency (PHE) declaration that has underpinned the country’s COVID-19 response efforts by providing the federal government with emergency powers, regulatory flexibilities and additional resources is currently set to expire in early
It is easy for those who are not health care professionals to overlook the tremendous potential for innovation in our field today. Similarly, anyone who is not a health policy wonk might not see the important ways policy is evolving to improve the delivery of care for millions of patients.
The pharmacy profession and patient care services delivered by the pharmacy team have evolved significantly over the past few years, bringing new opportunities and challenges.
New, exciting trends are emerging in community pharmacy practice, but what’s past is still prologue. Sal D’Angelo, a past president of the National Community Pharmacists Association/National Association of Retail Druggists, was the first person I heard say, “Get into politics or get out of pharmacy.
As we welcome 2023 and the beginning of the 118th Congress, HDA pharmaceutical distributor members’ role as a convener within the health care ecosystem will be more important than ever.
An article by McKinsey & Co. describes the current era with the words: “Return, Reimagine, Reinvent.” I cannot think of better positioning for our industry and for NACDS specifically in the association’s 90th Anniversary year. Our industry can look at the word “Return” from two angles.
No one knows for certain what the new year will bring for chain pharmacy operators.
While it may be difficult to imagine, shoppers are becoming even more health- and nutrition-conscious than they already are.
There’s never been a better time for health care leaders to think outside the [big] box. According to consulting firm McKinsey, health care providers are experiencing a confluence of forces driving a significant move from inpatient care to: • Distributed settings of care.
which inspires consumers to embrace proactive life choices through investment in accessible wellness and better-for-you methods —
Has anyone in the chain drug retailing community visited the new Wegmans in Brooklyn? Has anyone been to Dallas, Ga.
This space in the last issue of Chain Drug Review was devoted to the alarming results of a survey conducted by the National Community Pharmacists Association that show 58% of independent drug store owners think it is either somewhat or very likely that continued downward pressure on pharmacy reimbur
The phrase “inflection point” is overused, but there is no other way to describe where we have arrived in the consumer health care market in 2019, which is why Nicholas Hall, founder, executive chairman and creative solutions director of the Nicholas Hall Group of Cos.
elderberry, coconut oil, charcoal, melatonin and CBD. In Europe, elderberry has been used for centuries, but in the U.S. it’s been slower to gain traction, partly due to the virus that nearly decimated the
